Showing results (71-80 of 139) with videos related to
Sort By:
Pageof 14
Molecular Pharmacology|July 3, 2008
Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor functionTao Qi, George Christopoulos, Richard J Bailey, et al.Peptides|March 16, 2011
Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptorsTao Qi, Kien Ly, David R Poyner, et al.Molecular Pharmacology|January 25, 2018
Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide AntagonistsJason M Booe, Margaret L Warner, Amanda M Roehrkasse, et al.Organic & Biomolecular Chemistry|July 18, 2014
Convergent chemoenzymatic synthesis of a library of glycosylated analogues of pramlintide: structure-activity relationships for amylin receptor agonismRenata Kowalczyk, Margaret A Brimble, Yusuke Tomabechi, et al.Cephalalgia : an International Journal of Headache|February 7, 2017
CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measuredChristopher S Walker, Ann C Raddant, Michael J Woolley, et al.Biochemical Pharmacology|September 1, 2025
Pharmacological characterization of ubrogepant and atogepant in cAMP assays at human, rat, and mouse calcitonin family receptors in transfected cellsMhairi Nimick, Tyla I Alexander, Michael L Garelja, et al.Frontiers in Physiology|May 27, 2022
CGRP and the Calcitonin Receptor are Co-Expressed in Mouse, Rat and Human Trigeminal Ganglia NeuronsTayla A Rees, Andrew F Russo, Simon J O'Carroll, et al.Journal of Molecular Neuroscience : MN|January 27, 2004
The pharmacology of adrenomedullin receptors and their relationship to CGRP receptorsDebbie L Hay, Alex C Conner, Stephen G Howitt, et al.Trends in Pharmacological Sciences|July 5, 2011
Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug developmentJulia K Archbold, Jack U Flanagan, Harriet A Watkins, et al.The Journal of Pharmacology and Experimental Therapeutics|August 1, 2009
Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3Samuel D Robinson, Jacqueline F Aitken, Richard J Bailey, et al.Pageof 14